Literature DB >> 11514995

Direct coronary stenting: effect on coronary blood flow, immediate and late clinical results.

C Capozzolo1, F Piscione, G De Luca, A Cioppa, P Mazzarotto, D Leosco, P Golino, C Indolfi, M Chiariello.   

Abstract

Direct stenting (DS) was attempted in 99 coronary lesions in 94 patients while standard stenting (SS) was attempted in 113 lesions in 103 patients matched for clinical characteristics, stenosis type, and location and stent type. The angiographic result was also evaluated according to TIMI frame count method (TFC) before and after procedure. A clinical follow-up was performed 1 year after the procedure. Before the procedure, TIMI grade 3 flow was detected in 42 cases (42.4%), grade 2 in 40 cases (40.4%), grade 1 in 5 cases (5.1%), and grade 0 in 12 cases (12.1%) in the DS group; these data were similar in SS group. After the procedure, TIMI grade flow was 3 in 90 cases (92.8%) in DS group and in 87 (77.0%) in SS group (P < 0.005); grade 2 was observed in 7 case (7.2%) in DS group and in 25 (22.1%) in SS group (P < 0.005). Major adverse cardiac events during hospitalization and at follow-up were similar in two groups. Radiation exposure time and procedure costs per lesion were significantly reduced in DS group compared to SS group (10.1 +/- 8 min vs. 13.9 +/- 4.7 min, P < 0.001; and 1901 +/- 687 Euro vs. 2352 +/- 743 Euro, P < 0.001, respectively). This study confirms that, in selected patients, direct stenting is a safe and successful procedure, allowing a significant reduction in radiation exposure time and procedural costs compared to standard stenting technique. The angiographic success is confirmed by the improvement in TFC in all cases. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514995     DOI: 10.1002/ccd.1204

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  11 in total

1.  Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes.

Authors:  Monica Verdoia; Chiara Sartori; Patrizia Pergolini; Matteo Nardin; Roberta Rolla; Lucia Barbieri; Alon Schaffer; Paolo Marino; Giorgio Bellomo; Harry Suryapranata; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

2.  Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation.

Authors:  Giuseppe De Luca; Maurits T Dirksen; Christian Spaulding; Henning Kelbæk; Martin Schalij; Leif Thuesen; Bas van der Hoeven; Marteen A Vink; Christoph Kaiser; Carmine Musto; Tania Chechi; Gaia Spaziani; Luis Salvador Diaz de la Llera; Vincenzo Pasceri; Emilio Di Lorenzo; Roberto Violini; Harry Suryapranata; Gregg W Stone
Journal:  Clin Res Cardiol       Date:  2014-04-01       Impact factor: 5.460

3.  Current Assessments of the Adequacy of Myocardial Perfusion During Acute MI.

Authors:  Allen Chang; C Michael Gibson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-05

4.  Aspiration thrombectomy and primary percutaneous coronary intervention.

Authors:  G De Luca; H Suryapranata; M Chiariello
Journal:  Heart       Date:  2006-05-02       Impact factor: 5.994

Review 5.  Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years.

Authors:  Vijayalakshmi Kunadian; Caitlin Harrigan; Cafer Zorkun; Alexandra M Palmer; Katherine J Ogando; Leah H Biller; Erin E Lord; Scott P Williams; Michelle E Lew; Lauren N Ciaglo; Jacqueline L Buros; Susan J Marble; William J Gibson; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-04-20       Impact factor: 2.300

Review 6.  Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

Authors:  Giuseppe De Luca; Stefano Savonitto; Arnoud W J van't Hof; Harry Suryapranata
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

7.  Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study.

Authors:  Monica Verdoia; Alon Schaffer; Ettore Cassetti; Gabriella Di Giovine; Paolo Marino; Harry Suryapranata; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

Review 8.  Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials.

Authors:  Giuseppe De Luca; Maurits T Dirksen; Henning Kelbæk; Leif Thuesen; Marteen A Vink; Christoph Kaiser; Tania Chechi; Gaia Spaziani; Emilio Di Lorenzo; Harry Suryapranata; Gregg W Stone
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

9.  The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials.

Authors:  Lucia Barbieri; Monica Verdoia; Alon Schaffer; Matteo Nardin; Paolo Marino; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

10.  Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation.

Authors:  M Verdoia; A Schaffer; L Barbieri; G Di Giovine; G Bellomo; P Marino; H Suryapranata; G De Luca
Journal:  Neth Heart J       Date:  2016-07       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.